Axa’s National Healthcare NHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,900
Closed -$204K 1181
2022
Q1
$204K Sell
2,900
-12,500
-81% -$841K ﹤0.01% 1153
2021
Q4
$1.05M Sell
15,400
-5,100
-25% -$353K ﹤0.01% 946
2021
Q3
$1.44M Buy
20,500
+11,900
+138% +$865K ﹤0.01% 923
2021
Q2
$601K Buy
+8,600
New +$625K ﹤0.01% 1070
2020
Q4
Sell
-9,000
Closed -$561K 1315
2020
Q3
$561K Sell
9,000
-400
-4% -$25K ﹤0.01% 1019
2020
Q2
$596K Buy
9,400
+2,400
+34% +$161K ﹤0.01% 1034
2020
Q1
$502K Buy
+7,000
New +$554K ﹤0.01% 968
2014
Q4
Sell
-1,475
Closed -$82K 1450
2014
Q3
$82K Hold
1,475
﹤0.01% 1316
2014
Q2
$83K Buy
+1,475
New +$80.3K ﹤0.01% 1304
2013
Q3
Sell
-300
Closed -$14K 1304
2013
Q2
$14K Buy
+300
New +$14K ﹤0.01% 1221

Other funds holding NHC

Axa's NHC Position: Q2 2022 in Review

Axa sold out of National Healthcare (NHC) in Q2 2022, closing a stake of 2,900 shares — an estimated $204K sold.

Axa first reported a position in NHC in Q2 2013 and held it in 10 quarters. The position peaked at $1.44M in Q3 2021. 121 funds tracked by Wall St. Rank hold NHC as of Q2 2022.

  • Axa reported no remaining National Healthcare position as of Q2 2022 after selling out during the quarter.
  • Axa sold 2,900 National Healthcare shares in Q2 2022, an estimated $204K.
  • Axa first reported a position in National Healthcare in Q2 2013 and held it in 10 quarters.
  • Axa's National Healthcare position peaked at $1.44M in Q3 2021.
  • 121 funds tracked by Wall St. Rank held National Healthcare as of Q2 2022.

Based on Axa's 13F filing for Q2 2022, filed 15 Aug 2022.